NCT06163131Recruiting
The Effect of Treatment of Emphysema With Endobronchial Valves on the Diaphragm Mobility
Source: ClinicalTrials.gov · Last updated 8 Dec 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
In some patients with chronic obstructive pulmonary disease (COPD) the breathlessness is caused by hyperinflation of the lungs. This causes difficulty breathing air out and makes it harder to breath in new air and limits the movement of the diaphram. The diaphragm is the muscle used for breathing between the chest and the stomach. Some of these patients can receive treatment with endobronchial valves, where one-ways are inserted into the bronchial system the let out some of the excess air, and thereby relieve breathlessness. The goal of this observational study is to investigate the effect of endobronchial valves on the mobility of the diaphragm in patients with chronic obstructive pulmonary disease. The main questions it aims to answer are: * If the movement of the diaphragm improves after treatment with endobronchial valves. * If there is a link between improvement of diaphragm function and improvement of symptoms, lung function and physical ability. * If ultrasound scan immediately after the treatment will predict which patients will benefit from the treatment. Participants will undergo ultrasound before, 1 day after and 90 days after the procedure, and lung function examinations from their already planned control visits will be collected.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 35 (estimated)
- First submitted
- 21 Nov 2023
- Start date
- 27 Nov 2023
- Primary completion date
- 27 Nov 2026
- Lead sponsor
- Aarhus University Hospital
- Diseases
- COPD
- NCT number
- NCT06163131
What you commit to
- Study type: Observational
- Planned participants: 35
- From 27 Nov 2023 to the primary completion date, 27 Nov 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Neuromuscular disease interfering with diaphragm function
Other
- Pleural effusion at time of preoperative or 90-days postoperative ultrasound
Who the study is looking for
- Patients selected to receive treatment with endobronchial valves
- Signed informed consent
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Aarhus University Hospital Coordinator of this site? Confirm its status | Aarhus | Denmark | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.